Sale!

Buy 5 mg aripiprazole oral tablet online

$296.00

QuantityPer unitPrice
30 $9.88 $296.49
50 (5 x 10 each) $9.76 $487.81
90$9.67$870.46
100 (10 x 10 each) $9.66 $966.13
500$9.59$4,792.64
1000$9.58$9,575.77

Buy 5 mgaripiprazole oral tablet online. Aripiprazole is an atypical antipsychotic that is offered under the brand names Abilify and Aristada, among others. It’s most commonly used to treat schizophrenia and bipolar disorder. Other use include treating major depressive illness, tic disorders, and autism-related irritability. It can be given orally or via injection into a muscle. A Cochrane study discovered evidence of efficacy in the treatment of schizophrenia.

ARIPiprazole 5 MG Oral Tablet side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Buy 5 mg aripiprazole oral tablet online
Call your doctor at once if you have:

  • severe agitation, distress, or restless feeling;
  • twitching or uncontrollable movements of your eyes, lips, tongue, face, arms, or legs;
  • mask-like appearance of the face, trouble swallowing, problems with speech;
  • seizure ;
  • thoughts about suicide or hurting yourself;
  • severe nervous system reaction–very stiff (rigid) muscles, high fever, sweating, confusion, fast or uneven heartbeats, tremors, feeling like you might pass out;
  • low blood cell counts–sudden weakness or ill feeling, fever, chills, sore throat, swollen gums, painful mouth sores, red or swollen gums, skin sores, cold or flu symptoms, cough, trouble breathing; or
  • high blood sugar–increased thirst, increased urination, hunger, dry mouth, fruity breath odor, drowsiness, dry skin, weight loss.

You may have increased sexual urges, unusual urges to gamble, or other intense urges while taking this medicine. Talk with your doctor if this occurs.
Common side effects may include:

  • weight gain;
  • blurred vision;
  • nausea, vomiting, changes in appetite, constipation;
  • drooling;
  • headache, dizziness, drowsiness, feeling tired;
  • anxiety, feeling restless;
  • sleep problems (insomnia); or
  • cold symptoms such as stuffy nose, sneezing, sore throat.

ARIPiprazole 5 MG Oral Tablet dosing

Usual Adult Dose for Schizophrenia:

Immediate-release: The oral solution and oral tablets can be substituted on a mg-per-mg basis up to the 25 mg dose level; patients receiving 30 mg tablets should receive 25 mg of the oral solution.
Initial Dose: 10 or 15 mg orally once a day
Target Dose: 10 to 15 mg per day; effective dose range 10 to 30 mg per day; however, clinical trials have not found doses exceeding 10 or 15 mg per day to be more effective; dose increases, if needed should be at 2-week intervals to allow time to achieve steady state
Maximum Dose: 30 mg per day
ARIPiprazole 5 MG Oral Tablet Extended-Release IM Suspension [Abilify Maintena]:
Initial dose: 400 mg IM; continue ARIPiprazole 5 MG Oral Tablet 10 to 20 mg orally once a day for 14 days
Maintenance Dose: 400 mg IM once a month; should not be given sooner than 26 days after the previous injection
ARIPiprazole 5 MG Oral Tablet Lauroxil Extended-Release IM Suspension [Aristada(TM)]:
-For patients stable on oral ARIPiprazole 5 MG Oral Tablet 10 mg per day: Initial dose 441 mg IM; continue ARIPiprazole 5 MG Oral Tablet 10 mg orally once a day for 21 days
-For patients stable on oral ARIPiprazole 5 MG Oral Tablet 15 mg per day: Initial dose 662 mg IM; continue ARIPiprazole 5 MG Oral Tablet 15 mg orally once a day for 21 days
-For patients stable on oral ARIPiprazole 5 MG Oral Tablet 20 mg per day or higher: Initial dose 882 mg IM; continue ARIPiprazole 5 MG Oral Tablet dose orally once a day for 21 days
Maintenance Doses: 441 mg, 662 mg, or 882 mg IM monthly or 882 mg IM every 6 weeks; should not be given sooner than 14 days after the previous injection
Comments:
-Dosage adjustments are recommended in patients who are known CYP450 2D6 poor metabolizers and for patients taking concomitant CYP450 inhibitors or inducers; see dosage adjustment section for specific adjustments.
-Prior to initiating therapy with extended-release IM formulations, establish tolerability with oral formulation; it may take up to 2 weeks to fully assess tolerability due to the half-life of ARIPiprazole 5 MG Oral Tablet.
-Dose regimen adjustments (including addition of oral supplementation) will be needed for missed doses; see dose adjustments section.
Use: For the treatment of schizophrenia

Usual Adult Dose for Bipolar Disorder:

Monotherapy:
Initial dose: 15 mg orally once a day
Target dose: 15 mg orally once a day; may increase dose based on clinical response; dose increases, if needed should be at 2-week intervals to allow time to achieve steady state
Maximum dose: 30 mg per day
Adjunctive therapy with Lithium or Valproate:
Initial dose: 10 to 15 mg orally once a day
Target dose: 15 mg orally once a day; may increase dose based on clinical response; dose increases, if needed should be at 2-week intervals to allow time to achieve steady state
Maximum dose: 30 mg per day
Comments:
-The safety of doses greater than 30 mg per day has not been studied.
-The dose recommended for maintenance treatment is the same dose needed to stabilize patients during acute treatment; periodically reassess need for maintenance treatment.
-The oral solution and oral tablets can be substituted on a mg-per-mg basis up to the 25 mg dose level; patients receiving 30 mg tablets should receive 25 mg of the oral solution.
-Dosage adjustments are recommended in patients who are known CYP450 2D6 poor metabolizers and taking concomitant CYP450 inhibitors or inducers; see dosage adjustment section for specific adjustments.
Uses: This drug may be used as monotherapy or as an adjunct to lithium or valproate for the acute treatment of manic and mixed episodes associated with bipolar I disorder and for maintenance treatment of bipolar I disorder.

Usual Adult Dose for Agitated State:

For agitation associated with schizophrenia or bipolar mania:
Initial dose: 9.75 mg IM
Doses ranging from 5.25 mg to 15 mg may be considered when clinical factors warrant; no additional benefit has been demonstrated for 15 mg compared to 9.75 mg
Repeat doses: If additional doses are needed, allow at least 2 hours to elapse between dosing; the efficacy of repeated doses has not been studied.
Maximum dose: 30 mg per day
Comments: If ongoing therapy is clinically indicated, oral therapy should replace injections as soon as possible.
Use: For the treatment of agitation associated with schizophrenia or bipolar disorder, manic or mixed.

Usual Adult Dose for Depression:

As adjunctive treatment for patients already taking an antidepressant:
Initial dose: 2 to 5 mg orally once a day
Target dose: 5 to 10 mg orally once a day; titrate in increments up to 5 mg per day at intervals of no less than 1 week
Maximum dose: 15 mg per day
Comments: -Patients should be periodically reassessed to determine need for continued treatment.
-The oral solution and oral tablets can be substituted on a mg-per-mg basis up to the 25 mg dose level.

Use: As an adjunct to antidepressant therapy for the treatment of major depressive disorder.

Usual Pediatric Dose for Schizophrenia:

Age: 13 years or older:
Initial Dose: 2 mg orally once a day
After 2 days: Titrate to 5 mg orally once a day
After 4 days: Titrate to 10 mg orally once a day
Target Dose: 10 mg orally once a day; effective dose range 10 to 30 mg per day; however, clinical trials have not found doses exceeding 10 mg per day to be more effective; dose increases, if needed should be in 5 mg increments at 2-week intervals in order to allow time to achieve steady state
Maximum Dose: 30 mg per day
Comments:
-Maintenance treatment in the adolescent population has not been evaluated; extrapolating from adult data, it is recommended that responding patients be continued beyond the acute response, but at the lowest dose needed to maintain remission.
-Periodically reassess need for maintenance treatment.
-The oral solution and oral tablets can be substituted on a mg-per-mg basis up to the 25 mg dose level; patients receiving 30 mg tablets should receive 25 mg of the oral solution.
-Dosage adjustments are recommended in patients who are known CYP450 2D6 poor metabolizers and taking concomitant CYP450 inhibitors or inducers; see dosage adjustment section for specific adjustments.
Use: For the treatment of schizophrenia

Usual Pediatric Dose for Bipolar Disorder:

Age: 10 years or older: As monotherapy or as adjunctive therapy with lithium or valproate:
Initial Dose: 2 mg orally once a day
After 2 days: Titrate to 5 mg orally once a day
After 4 days: Titrate to 10 mg orally once a day
Target Dose: 10 mg orally once a day; dose increases, if needed should be in 5 mg increments at 2-week intervals in order to allow time to achieve steady state
Maximum Dose: 30 mg per day
Comments: The dose for maintenance treatment is the same dose needed to stabilize patients during acute treatment; periodically reassess need for maintenance treatment.
-The oral solution and oral tablets can be substituted on a mg-per-mg basis up to the 25 mg dose level; patients receiving 30 mg tablets should receive 25 mg of the oral solution.
-Dosage adjustments are recommended in patients who are known CYP450 2D6 poor metabolizers and taking concomitant CYP450 inhibitors or inducers; see dosage adjustment section for specific adjustments.
Uses: This drug may be used as monotherapy or as an adjunct to lithium or valproate for the acute treatment of manic and mixed episodes associated with bipolar I disorder and for maintenance treatment of bipolar I disorder.

Usual Pediatric Dose for Autism:

Age: 6 to 17 years: Dose should be individualized according to tolerability and response.
Initial dose: 2 mg orally once a day
Dose titration: Increase dose to 5 mg orally once a day, with subsequent increases to 10 mg or 15 mg orally once a day if needed; dose adjustments in increments of up to 5 mg per day should occur at intervals of no less than 1 week.
Maximum Dose: 15 mg orally once a day
Comments: The efficacy of maintenance treatment of irritability associated with autistic disorder has not been evaluated; patients should be periodically reassessed to determine need for continued treatment.
-The oral solution and oral tablets can be substituted on a mg-per-mg basis up to the 25 mg dose level.
-Dosage adjustments are recommended in patients who are known CYP450 2D6 poor metabolizers and taking concomitant CYP450 inhibitors or inducers; see dosage adjustment section for specific adjustments.
Use: Treatment of irritability associated with autistic disorder :

Usual Pediatric Dose for Tourette’s Syndrome:

Age: 6 to 18 years:
-For patients weighing less than 50 kg:
Initial Dose: 2 mg orally once a day
After 2 days: Titrate to recommended dose of 5 mg orally once a day; in patients who do not achieve optimal control of tics; may increase dose to 10 mg once a day; dose adjustments should occur gradually at intervals of no less than 1 week
Maximum Dose: 10 mg orally once a day
-For patients weighing 50 kg or more:
Initial Dose: 2 mg orally once a day
After 2 days: Titrate to 5 mg orally once a day
On day 8: Titrate to recommended dose of 10 mg orally once a day; in patients who do not achieve optimal control of tics; may increase dose in increments of 5 mg per day at intervals of no less than 1 week
Maximum Dose: 20 mg orally once a day
Comments: Periodically assess patients to determine continued need for maintenance treatment.
-The oral solution and oral tablets can be substituted on a mg-per-mg basis up to the 25 mg dose level.
-Dosage adjustments are recommended in patients who are known CYP450 2D6 poor metabolizers and taking concomitant CYP450 inhibitors or inducers; see dosage adjustment section for specific adjustments.
Use: Treatment of Tourette’s disorder Buy 5 mg aripiprazole oral tablet online

Category:

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.